Samay (NSF-2112096) develops an artificial-intelligence assisted wearable patch called “Sylvee” that can diagnose chronic obstructive pulmonary disease (COPD) with 90% accuracy. The company was selected as the grand prize winner for the 2024 MedTech Innovator competition, being the first Latin American-owned company accepted in its 12-year history. Article via MD+DI